Report copyright - Company Overview Investor Presentation NASDAQ: SLS · 2019-01-06 · CLINICAL PROGRAM OVERVIEW Galinpepimut-S (GPS): WT1 peptide vaccine E39: Folate binding peptide vaccine • Acute
Please pass captcha verification before submit form
Please pass captcha verification before submit form